Contact person:

CEO: Jónas Einarsson
PHONE: +47 480 96 355


Founded in: 1986

Number of employees: 4

CEO: Jónas Einarsson

Company Description:

The Radium Hospital Research Foundation (RF) is an experienced oncology focused early stage evergreen fund. Far from being a passive investor, we take an active part in our portfolio companies’ further development. Our experienced team now manages an exciting balanced portfolio of 9 biotech companies with particular strengths in immuno-oncology.

We invest in and develop companies based on the continuing flow of state-of-the-art innovations from leading research institutions.

RF has a strong collaboration with Sarsia Seed and Birk Venture. We are member of Norwegian Venture Capital Association (NVCE – Norsk Venturekapitalforening).

Our portfolio:

Privately owned companies:
Targovax AS –
Ultimovacs AS –
Vaccibody AS –
Nextera AS –
Oncoinvent AS –
Biomolex AS –

Listed companies:
Photocure ASA –
PCI Biotech AS –
Nordic Nanovector AS –